GPR15 and cancer: For RUNX3→GPR15 (Figure 2A), the regulatory intensity was reduced from normal to cancer with the intensity value being 0.441 (normal) and −0.010 (cancer), and the expression level of the target, GPR15, significantly decreased as shown.